Overexpression of anti-apoptotic factor Bcl2 in cancer cells can be achieved by various post-transcriptional mechanisms, for example aberrant expression of miRNAs [42] or increased protein phosphorylation and stabilization resulting in resistance toward cisplatin-induced cell death [43]. The gene discussed is BCL2; the disease is cancer.